Use of monoclonal antibodies in patients with multiple sclerosis in the practice of a neurologist

Multiple sclerosis (MS) ranks first for prevalence among diseases affecting the CNS white matter with 2.5 million cases estimated globally. InRussia, the number of cases is about 200 thousand. MS in most cases has a wavy course (periods of exacerbations and remissions), over time the progression of...

Полное описание

Библиографические подробности

Главный автор:	N. Yu. Lashch
Формат:	Artigo
Язык:	Russo
Опубликовано:	Remedium Group LLC 2020-03-01
Серии:	Медицинский совет
Предметы:	multiple sclerosis monoclonal antibody dmt highly active multiple sclerosis safety efficiency alemtusumab immunomodulatory therapy
Online-ссылка:	https://www.med-sovet.pro/jour/article/view/5523
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!